Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-020161

Exec. VP, European Commercial sold 616 shares at $7.17 ($4,418)

  • Exec. VP, European Commercial acquired 1,297 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Daniell Richard Exec. VP, European Commercial 2020-03-17 Option exercise +1,297 11,016 D: show line 1 in the form
Daniell Richard Exec. VP, European Commercial 2020-03-17 Sale −616 $7.17 $4,418 10,400 D: show line 2 in the form
Open-market sales · 616 sh · avg $7.17 · $4,418

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Daniell Richard Exec. VP, European Commercial 2020-03-17 Option exercise · Restricted Share Units −1,297 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…